J. Nedvěd
Microbiological Institute, Academy of Sciences of the Czech Republic, Prague,
M. Hajdúch
Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University and Faculty Hospital, Olomouc,
K. Lemr
Department of Analytical Chemistry, Faculty of Science, Palacký University, Olomouc
V. Havlíček
Microbiological Institute, Academy of Sciences of the Czech Republic, Prague,
Abstrakt
Tumor markers play an important role in cancer diagnostics. However, with the exception of selected fusion genes and proteins, there are no specific compounds for unambiguous cancer diagnosis. Oncologists must combine many markers to assess diagnosis, staging, prognosis and prediction of therapeutic response. Mass spectrometry (MS) is a powerful technique which can help to identify new biomarkers and/or to refine information about marker candidates. Recent years have witnessed new approaches in MS analysis for dicovery of cancer biomarkers. This review highlights some recent findings and trends in cancer diagnosis.
